| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | -0.059 | 0.2 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |